About
Doug Ethell is a neuroscientist and biotechnology founder focused on Alzheimer's disease. He is the founder, chairman, and CEO of Leucadia Therapeutics, where his academic research underpins the company's medical-device approach to restoring cerebrospinal fluid drainage. Before entering industry, he held research and faculty roles at the Scripps Research Institute, La Jolla Institute for Immunology, UC Riverside, and Western University of Health Sciences, where he founded the Molecular Neurobiology Group and chaired neuroscience.
Areas of interest
Alzheimer's diseaseneurosciencebiotechlongevityneurodegenerationcerebrospinal fluid clearancemedical research